Acadia Healthcare Company (ACHC) Joins The Russell 2000, Is The Upside Already Priced In?
Acadia Healthcare Company (ACHC) has been added to the Russell 2000 index, reflecting a change in its market capitalization footprint. Despite recent stock momentum, the company faces conflicting valuation assessments with one narrative suggesting it is 147.3% overvalued at a fair value of $11.94, while a Discounted Cash Flow model indicates a fair value of $85.74. Investors are encouraged to further analyze the underlying data and potential pressure points like the reported net income loss and declining 3-year total shareholder return.
Does Acadia Healthcare (ACHC) Joining the Russell 2000 Reframe Its Behavioral Health Investment Narrative?
Acadia Healthcare (ACHC) was moved from the Russell 1000 to the Russell 2000 Index, recategorizing it into the small-cap value universe. This technical shift could affect its investor base and liquidity but doesn't fundamentally change its near-term financials. Key factors for its investment narrative remain execution on facility performance, leadership by CEO Debra Osteen, and managing risks associated with Medicaid reimbursement policies, rather than the index change itself.
Does Acadia Healthcare (ACHC) Joining the Russell 2000 Reframe Its Behavioral Health Investment Narrative?
Acadia Healthcare (ACHC) has moved from the Russell 1000 to the Russell 2000 index, recategorizing it into the smaller-capitalization value universe. This shift is primarily technical, influencing liquidity and investor perception rather than immediate fundamentals. The article suggests that the return of CEO Debra Osteen and her leadership in addressing operational challenges might be more significant for Acadia’s future than the index change itself.
Cantor Fitzgerald reiterates Acadia Healthcare stock Neutral rating
Cantor Fitzgerald has reiterated a Neutral rating on Acadia Healthcare (NASDAQ:ACHC) with a $30.00 price target, noting that June 2026 data was more negative for the company compared to earlier months in 2026. This comes despite the stock's significant surge and being considered undervalued by InvestingPro. Other firms like Jefferies and KeyBanc have offered differing perspectives and price targets, while the company also faces a recent legal judgment.
Acadia Healthcare stock hits 52-week high at 30.24 USD By Investing.com
Acadia Healthcare Company Inc. (ACHC) has reached a 52-week high of $30.26, driven by a 108% year-to-date surge and an 18% jump in the past week. The stock is considered undervalued by InvestingPro analysis, with analysts expecting profitability and net income growth. Recent developments include a $105 million jury payout by a subsidiary and stock rating upgrades from Jefferies and KeyBanc due to new management and operational improvements.
Acadia Healthcare Company (ACHC) Joins The Russell 2000, Is The Upside Already Priced In?
Acadia Healthcare Company (ACHC) has moved into the Russell 2000, Russell 2000 Value, and Russell 2000 Dynamic indices, reflecting a shift in its market cap classification. This re-indexing follows strong short-term stock momentum, with a 106.65% year-to-date return, though its 3-year total shareholder return has declined 62.71%. The article presents conflicting valuation views, with one narrative suggesting the stock is 147.3% overvalued at $29.53 compared to a fair value of $11.94, while a DCF model points to a higher fair value of $85.74.
Acadia Healthcare Company, Inc.(NasdaqGS:ACHC) added to Russell 2000 Value Benchmark
Acadia Healthcare Company, Inc. (ACHC) has been added to the Russell 2000 Value Benchmark on June 29, 2026. This inclusion follows several adjustments to Russell indices on the same date, including its removal from the Russell Midcap Value Benchmark, Russell 2000 Index, and Russell 1000 Value Benchmark. Acadia Healthcare is a prominent provider of behavioral healthcare services across the United States and Puerto Rico.
Acadia Healthcare Company, Inc.(NasdaqGS: ACHC) added to Russell 2000 Index
Acadia Healthcare Company, Inc. (NasdaqGS: ACHC) has been added to the Russell 2000 Index, as announced on June 29, 2026. This inclusion comes alongside its removal from several other Russell indices, including the Russell Midcap Value Benchmark, Russell 1000 Value Benchmark, Russell 1000 Dynamic Index, Russell Midcap Index, and Russell 1000 Index. The behavioral healthcare services provider saw its shares rise earlier in June after multiple analyst upgrades and price target adjustments.
Acadia Healthcare Company, Inc.(NasdaqGS:ACHC) dropped from Russell 1000 Value Benchmark
Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) has been removed from the Russell 1000 Value Benchmark. This news follows a recent trend where the company was also dropped from the Russell 1000 Dynamic Index. This change in index inclusion could affect the stock's visibility and institutional investment.
Price to book forward of Acadia Healthcare Company, Inc. – NASDAQ:ACHC
This article provides a financial data point for Acadia Healthcare Company, Inc. (NASDAQ: ACHC), specifically its price-to-book forward ratio. It appears to be a stub or a data point from a financial platform, showing the period, value, and change for this metric. The content highlights the company's stock information on the Nasdaq Stock Market.
Price to book forward of Acadia Healthcare Company, Inc. – XETR:7RA
This article provides financial information for Acadia Healthcare Company, Inc. (XETR:7RA) on TradingView, specifically focusing on its "Price to book forward" metric. It appears to be a stub or a section of a larger financial data presentation, indicating market status as closed with no trades.
Acadia Healthcare Company, Inc. Actuals & Estimates (MIL:1ACHC)
This article provides an overview of Acadia Healthcare Company, Inc. (MIL:1ACHC) stock performance, financials, and analyst forecasts. It covers the current stock price, historical highs and lows, market capitalization, earnings, revenue, and future outlook based on analyst opinions. The company's next earnings report is expected on August 4, 2026, with analysts showing a "strong buy" rating for its stock.
Form 4 Acadia Healthcare Company Inc For: 26 June By Investing.com
This article reports on a Form 4 filing for Acadia Healthcare Company Inc. on June 26. These filings are mandatory SEC documents used to report changes in beneficial ownership of a company's stock by insiders. The brief piece indicates that further details on this filing can be found by navigating to the relevant section on Investing.com.
Acadia Healthcare (ACHC) EVP Farley reports tax-withholding share disposition
Acadia Healthcare Company, Inc. EVP Brian Farley reported a routine tax-withholding disposition of 1,370 common stock shares at $26.24 per share to cover tax obligations. This transaction was not an open-market sale, and Farley still directly holds 137,752 shares following the event. The Form 4 filing indicates a neutral sentiment and impact on the company's valuation.
Enterprise value to revenue forward of Acadia Healthcare Company, Inc. – NASDAQ:ACHC
This article provides an overview of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) financials on TradingView, specifically focusing on its enterprise value to revenue forward metric. It indicates that the market was closed at the time of viewing, with no trades. The article is primarily metadata and navigational structure from TradingView, rather than a detailed financial analysis.
ACHC Stock Price Prediction 2025-2026 | Acadia Healthcare Company Inc Forecast
24/7 Wall St. provides a stock price prediction for Acadia Healthcare Company Inc (ACHC), setting a 12-month target price of $36.22, suggesting a 45.10% upside from the current price of $24.96. The analysis includes optimistic and conservative scenarios, highlighting potential catalysts and risks. The article also presents a 5-year and 2030 price projection, noting that the company currently holds a "BUY" rating from 24/7 Wall St. and a significant portion of Wall Street analysts.
Price to earnings forward of Acadia Healthcare Company, Inc. – NASDAQ:ACHC
This article provides financial information for Acadia Healthcare Company, Inc. (NASDAQ: ACHC), specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or data placeholder from TradingView, indicating that specific value and change data for the P/E forward metric would be presented for different periods.
How Acadia Healthcare Company Inc. (ACHC) Affects Rotational Strategy Timing
Acadia Healthcare Company Inc. (ACHC) is exhibiting a neutral sentiment across all time horizons, indicating a wait-and-see approach for investors. The article details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—each tailored to different risk profiles and holding periods, with specific entry points, targets, and stop losses. A notable risk-reward setup of 101.3:1 is highlighted, targeting a 27.3% gain against a 0.3% risk.
How Acadia’s Behavioral Health Expansion and Partnerships Will Impact Acadia Healthcare Company (ACHC) Investors
Acadia Healthcare has expanded its behavioral health facilities and partnerships to meet rising mental health needs in the U.S., a move that aligns with policy support and insurer demand. While this expansion aims to boost revenue and capacity, investors should consider whether new sites can overcome challenges like rising Medicaid pressures, startup losses, and legal costs to restore consistent profitability. The article also highlights Acadia's projected revenues and earnings, contrasting them with pessimistic analyst forecasts, and suggests accessing a full research report for a comprehensive view.
Can Acadia's Turnaround Strategy Drive Long-Term Shareholder Value?
Acadia Healthcare Company, Inc. (ACHC) is demonstrating a turnaround, shifting from growth pursuit to maximizing returns from its existing operations in behavioral health. The company is addressing previous challenges, strengthening compliance, and improving workforce retention. This strategy has led to increased revenues and raised EBITDA guidance, positioning Acadia for improved profitability as demand for mental health services rises.
Acadia Healthcare Company Inc (ACHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey
This article for Acadia Healthcare Company Inc (ACHC) on TradingKey focuses on the company's revenue breakdown. However, it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page provides basic stock information and a framework for where such data would typically be presented.
Acadia Healthcare Company Inc (ACHC) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Acadia Healthcare Company Inc (ACHC), listing its major shareholders and their respective proportions. It also provides a breakdown of shareholder types, institutional shareholding trends over several quarters, and recent shareholder activity with changes in holdings for key investors. Additionally, it lists several ETFs with notable proportions of ACHC.
Acadia Healthcare Company (ACHC) 47th Annual Raymond James Institutional Investor Conference summary
Acadia Healthcare Company (ACHC) presented at the 47th Annual Raymond James Institutional Investor Conference, highlighting its position as a leading behavioral health provider with $3.3 billion in projected 2025 revenue. The company emphasized strategic priorities including patient care, operational efficiency, and a significant reduction in growth CapEx for 2026 and 2027 to support positive cash flow. While a New York Medicaid policy change is expected to affect same-facility growth, ACHC projects overall patient day growth and identifies a $200 million EBITDA opportunity from new bed expansion.
Acadia Healthcare Company (ACHC) Q2 2024 earnings summary
Acadia Healthcare Company (ACHC) reported an 8.8% year-over-year revenue increase to $796 million in Q2 2024, driven by higher patient days and improved rates. Net income was $78.5 million, with adjusted EBITDA growing 7.6% to $187.6 million. The company updated its 2024 guidance, projecting revenue between $3.18 billion and $3.225 billion, and continues to expand bed capacity and open new facilities.
Acadia Healthcare Company (ACHC) Stock Could Be 108.3% Overvalued After Expansion News
Acadia Healthcare Company's recent facility expansion and partnerships have drawn investor attention, with shares rebounding sharply this year but still lagging over three years. While a popular narrative suggests the stock is 108.3% overvalued with a fair value of $11.94, a different analysis using a Discounted Cash Flow model indicates it could be undervalued at $24.87, with an estimated future cash flow value of $83.20. Investors are encouraged to assess both perspectives to determine the true value and risks associated with ACHC.
Is Acadia Healthcare Company, Inc. (ACHC) A Good Stock To Buy Now?
The article discusses Acadia Healthcare Company, Inc. (ACHC) as a potentially good investment, highlighting its role as a leading behavioral healthcare provider with growing demand in the mental health and addiction treatment industry. The analysis notes ACHC's expansion strategies, favorable market conditions with increasing insurance coverage, and strong technical indicators suggesting continued upward momentum. While acknowledging its potential, the article also suggests that certain AI stocks might offer greater returns in a shorter timeframe.
Acadia Healthcare Company Inc (ACHC) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Acadia Healthcare Company Inc (ACHC), detailing its current earnings forecast score, average price target from analysts, and a breakdown of analyst ratings. It also includes expected revenue for the next quarter and recent EPS performance. The data indicates a "Buy" trend based on analyst consensus.
Will Acadia’s Raised Full-Year Outlook but Softer Near-Term Guidance Change Acadia Healthcare's (ACHC) Narrative
Acadia Healthcare (ACHC) reported strong quarterly revenue and raised its full-year outlook, exceeding expectations more than any hospital peer. However, its near-term revenue and earnings guidance fell short of market forecasts, creating tension between the company's long-term growth plans and investor confidence. The article explores how this mixed guidance, coupled with the return of former CFO David Duckworth, could impact Acadia's investment narrative, particularly concerning its capital allocation, expansion-related risks, and reliance on Medicaid programs.
Acadia Healthcare Company Inc (ACHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Acadia Healthcare Company Inc (ACHC), detailing its current price momentum, support and resistance levels, and indicator readings. It shows that ACHC has a price momentum score of 6.48 and is currently trading between a resistance of $26.08 and a support of $21.68. The analysis concludes with a "Sell" signal based on various technical indicators and moving averages.
Stronger Full‑Year Outlook But Softer Near‑Term Guidance Might Change The Case For Investing In Acadia (ACHC)
Acadia Healthcare Company recently reported a 7.6% year-on-year revenue increase, surpassing analyst expectations, but provided softer near-term guidance for revenue and EPS. Despite the stronger full-year outlook and management's focus on disciplined execution in behavioral health, investors are primarily reacting to the weaker short-term forecast. This has led to a sharp share price drop, prompting a re-evaluation of the company's investment narrative, although the long-term demand and facility performance still appear intact.
Will Acadia’s Raised Full-Year Outlook but Softer Near-Term Guidance Change Acadia Healthcare's (ACHC) Narrative
Acadia Healthcare recently reported better-than-expected quarterly revenue and raised its full-year outlook, exceeding hospital peers. However, its near-term revenue and EPS guidance fell short of market forecasts, creating tension between its growth plans and investor confidence. The company's investment narrative relies on rising demand for behavioral health services and facility expansion, despite current execution and reimbursement pressures, compounded by the return of a former CFO to stabilize confidence around expansion risks.
(ACHC) and the Role of Price-Sensitive Allocations
This article analyzes Acadia Healthcare Company Inc. (NASDAQ: ACHC) stock, highlighting conflicting sentiment across different time horizons and suggesting choppy conditions. It details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, providing entry points, targets, and stop losses. The analysis also identifies a significant 102.7:1 risk-reward setup.
Q1 Earnings Outperformers: Acadia Healthcare (NASDAQ:ACHC) And The Rest Of The Hospital Chains Stocks
The first quarter earnings season revealed mixed results for hospital chains. While some companies like Universal Health Services outperformed revenue expectations, most saw their stock prices decline post-earnings, averaging a 16% drop. Acadia Healthcare, despite a revenue beat, was considered the weakest performer due to missing future EPS guidance, while Universal Health Services had the strongest Q1 among its peers.
Cash from investing activities of Acadia Healthcare Company, Inc. – XETR:7RA
This article provides financial data specifically on the "Cash from investing activities" for Acadia Healthcare Company, Inc. (XETR:7RA). It notes that the market is closed and offers no specific values or changes in this snippet, serving more as a heading within a financial data platform.
Acadia Healthcare (ACHC) Is Up 8.6% After Analyst Upgrade And Higher 2026 Guidance Outlook
Acadia Healthcare (ACHC) saw an 8.6% increase after Raymond James upgraded its rating and the company improved its 2026 earnings and EBITDA guidance. While the company's Q1 2026 results showed revenue growth and reaffirmed full-year guidance, investors are cautioned to consider ongoing legal and regulatory investigations and differing analyst perspectives on compliance costs and Medicaid exposure. Despite the positive news, some analysts remain more cautious, and Simply Wall St encourages investors to conduct their own research.
Acadia Healthcare (ACHC) Is Up 8.6% After Analyst Upgrade And Higher 2026 Guidance Outlook
Acadia Healthcare (ACHC) stock rose 8.6% following an analyst upgrade from Raymond James and a strong Q1 2026 report with modestly higher 2026 earnings and EBITDA guidance. While the company aims to improve underperforming facilities and expand, investors should be aware of ongoing legal and regulatory investigations. The article suggests that despite optimism, the stock may still be overvalued, with some analysts forecasting a significant downside from current prices.
Net debt of Acadia Healthcare Company, Inc. – XETR:7RA
This article provides financial information for Acadia Healthcare Company, Inc. (XETR:7RA), focusing specifically on its net debt. It presents the period, value, change, and percentage change for the company's net debt. The content is presented within the context of market data provided by ICE Data Services and FactSet.
Jefferies recaps meetings with Healthcare Services companies
Jefferies reported on its meetings with various Healthcare Services companies, noting that healthcare service stocks saw an average gain of 0.5% last week while the S&P 500 declined. The firm upgraded Acadia Healthcare and maintained BrightSpring Health Services as a top pick, citing strong growth trajectories and strategic developments. Discussions with HCA Healthcare and Surgery Partners revealed insights into demand, payer mix challenges, and growth strategies within the hospital and surgery center sectors.
Assessing Acadia Healthcare Company (ACHC) Valuation After Analyst Upgrades And Higher 2026 Guidance
Acadia Healthcare Company (ACHC) is gaining attention after a strong first quarter, leading to an analyst upgrade and increased 2026 guidance. Despite recent share price momentum, the company's valuation is split, with one narrative suggesting it's 105% overvalued at $11.94, while a DCF model indicates it's 70.8% undervalued with a fair value of $83.90. The discrepancy highlights the importance of evaluating both sentiment and cash flow analysis.
Book value per share of Acadia Healthcare Company, Inc. – XETR:7RA
This article provides the book value per share for Acadia Healthcare Company, Inc. (XETR:7RA). It includes an overview of financial data, news, and community forecasts for the company listed on the Deutsche Borse Xetra. The content is primarily a data placeholder and navigational structure from TradingView.
Tangible book value per share of Acadia Healthcare Company, Inc. – XETR:7RA
This article provides financial information for Acadia Healthcare Company, Inc. (XETR:7RA), focusing specifically on its tangible book value per share. It lists the company's stock exchange details and mentions that the market is closed without any trades. The content is primarily a data point within a larger financial platform rather than an analytical piece.
ACHC News | ACADIA HEALTHCARE CO INC (NASDAQ:ACHC)
This article provides recent news and analysis for Acadia Healthcare Co Inc (NASDAQ:ACHC). It lists several recent headlines from ChartMill and Zacks, highlighting events such as a Q1 revenue miss, Q4 2025 revenue beat coupled with legal charges, and stock performance alongside options trading interest. The latest stock price and after-hours trading information are also included.
Why is Acadia Healthcare Company (ACHC) Highly Favored by Hedge Funds
Acadia Healthcare Company (ACHC) is highly favored by hedge funds and considered one of the 10 most promising mid-cap healthcare stocks. Raymond James upgraded ACHC to a Strong Buy with a $39 price target, citing strong Q1 results and increased guidance. However, Cantor Fitzgerald maintained a Neutral rating, noting that bad debt and denial patterns could neutralize operational improvements despite core performance.
Acadia Healthcare Data Breach Lawsuit Investigation
Shamis & Gentile P.A. is investigating a data breach affecting Acadia Healthcare Company, Inc., a major behavioral healthcare provider. The breach, which occurred between March 21 and March 25, 2026, exposed sensitive personal information of individuals, including names, addresses, dates of birth, treatment details, and health insurance information. Individuals affected by the breach may be entitled to compensation and are encouraged to contact the law firm.
Acadia Healthcare Data Breach Exposes Social Security Numbers
Acadia Healthcare, a major behavioral healthcare provider, disclosed a data breach that occurred in March 2026 due to an unauthorized party gaining access to an employee email and SharePoint account via social engineering. The breach exposed patient information including names, dates of birth, treatment details, health insurance information, and for some, Medicare Health Insurance Claim Numbers which may contain Social Security numbers. Acadia Healthcare has begun notifying affected individuals and is providing resources for identity theft protection and a dedicated helpline.
ACHC Stock Price Prediction 2025-2026 | Acadia Healthcare Company Inc Forecast
24/7 Wall St. has set a 12-month target price of $34.87 for Acadia Healthcare Company Inc (ACHC), indicating a potential 35.54% upside from its current price of $25.73. The analysis includes an optimistic scenario at $38.73 and a conservative scenario at $27.50, with Wall Street analysts showing a largely positive sentiment (7 Buy, 6 Hold, 1 Sell). The long-term projection for ACHC in 2030 averages $51.09, suggesting a significant return.
Jefferies Upgrades Acadia Healthcare(ACHC.US) to Buy Rating, Raises Target Price to $30
Jefferies analyst Brian Tanquilut has upgraded Acadia Healthcare (ACHC.US) to a "buy" rating, increasing the target price from $15 to $30. Tanquilut has a 49.2% success rate and a 4.5% average return over the past year, according to TipRanks data. This move indicates a positive outlook on Acadia Healthcare's stock performance.
Jefferies upgrades Acadia Healthcare stock rating on management outlook
Jefferies upgraded Acadia Healthcare (NASDAQ:ACHC) to Buy from Hold, raising its price target to $30.00, citing enhanced operational stability and earnings visibility under new management. Analysts predict profitability for the company this year, with the stock currently undervalued according to InvestingPro's Fair Value analysis. Other firms also show confidence, with Raymond James upgrading to Strong Buy and Guggenheim raising its price target due to strong volume growth.
Responsive Playbooks and the ACHC Inflection
This article provides an AI-generated analysis of Acadia Healthcare Company Inc. (NASDAQ: ACHC), indicating a neutral near-term sentiment that could moderate mid-term weakness. It highlights an exceptional risk-reward short setup and outlines three distinct institutional trading strategies for various risk profiles and holding periods, including position trading, momentum breakout, and risk hedging. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
Should Strong Acute Psychiatric Results and Raised Outlook Require Action From Acadia Healthcare (ACHC) Investors?
Acadia Healthcare (ACHC) reported better-than-expected first-quarter earnings, driven by strong growth in its Acute Inpatient Psychiatric Facilities business and increased patient days. This positive performance has led to raised second-quarter guidance, indicating near-term operational momentum for the company. While the strong results address immediate utilization concerns, long-term questions regarding return on invested capital, earnings sustainability, and execution risks remain for investors.
